Parvovirus B19 IgG Control Serum BC122G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Parvovirus
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC122G Categories: control serum, Virion/Serion kits Tags: ELISA control serum, IgG, Parvovirus

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Parvovirus B19 reactive IgG
species reactivity	Parvovirus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Parvovirus B19 IgG Control Serum BC122G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Parvovirus B19 NS1 Antigen (BA122VSNS1) Parvovirus B19 VP1 Antigen (BA122VSVP1) Parvovirus B19 PepA (VP1 unique) Antigen (BA122VSVP1A) Parvovirus B19 PepB (VP2 C-term) Antigen (BA122VSVP1B) Parvovirus B19 PepC (VP1 N-term) Antigen (BA122VSVP1C) Parvovirus B19 PepD (VP1 C-term) Antigen (BA122VSVP1D) Parvovirus B19 VP2 Antigen (BA122VSVP1E) Parvovirus B19 VLP Antigen (BA122VSVP2) Parvovirus B19 IgG Control Serum (BC122G) Parvovirus B19 IgM Control Serum (BC122M) Parvovirus IgG ELISA Kit (ESR122G) Parvovirus IgM ELISA Kit (ESR122M)

target relevance

human antibody anti-Parvovirus

Parvovirus

Description
Group of viruses that cause gastrointestinal, respiratory, and systemic infections in humans and animals

Structure
Parvoviruses are small, non-enveloped viruses containing a linear single-stranded DNA genome and belonging to the family Parvoviridae. The viral capsid possesses an icosahedral structure and lacks a lipid envelope, contributing to exceptional environmental stability and resistance to many common disinfectants. Members of the Parvoviridae family infect a wide range of vertebrate and invertebrate hosts and include important human and veterinary pathogens. Human Parvovirus B19 is the best-known human pathogen of the group and is the causative agent of erythema infectiosum (fifth disease). Other parvoviruses, such as canine parvovirus and feline panleukopenia virus, cause severe disease in animals. Parvoviruses preferentially infect rapidly dividing cells because they rely on host cellular machinery for viral DNA replication.

Diagnosis
The diagnosis of parvovirus infection depends on the specific virus involved and may include serological, molecular, and antigen detection methods. Human Parvovirus B19 infection is commonly diagnosed through the detection of virus-specific IgM and IgG antibodies or by polymerase chain reaction (PCR) assays that identify viral DNA in blood or tissue samples. In veterinary medicine, infections such as canine parvovirus are frequently diagnosed using ELISA-based antigen detection tests on fecal samples, while PCR provides highly sensitive confirmation and strain identification. Laboratory findings and clinical presentation are often used in conjunction with specific diagnostic tests to establish the diagnosis.

Symptoms
Parvovirus infections produce a broad spectrum of clinical manifestations depending on the host species and the specific virus involved. Human Parvovirus B19 infection commonly causes erythema infectiosum, characterized by a distinctive 'slapped-cheek' rash, mild fever, headache, and malaise. In adults, joint pain and arthritis-like symptoms may occur. In immunocompromised individuals or patients with underlying hematological disorders, severe anemia may develop due to infection of erythroid precursor cells. During pregnancy, fetal infection may result in hydrops fetalis or fetal loss. Animal parvoviruses, particularly canine parvovirus, commonly cause severe gastrointestinal disease characterized by vomiting, hemorrhagic diarrhea, dehydration, lethargy, and potentially fatal secondary infections.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application of the Parvovirus B19 IgG Control Serum BC122G?

The Parvovirus B19 IgG Control Serum BC122G is designed for use as an IgG control serum in ELISA assays, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays.

How should the Parvovirus B19 IgG Control Serum BC122G be stored to maintain its stability?

This control serum should be stored at temperatures between 2 to 8 degrees Celsius to preserve its integrity.

What is the target specificity of the Parvovirus B19 IgG Control Serum BC122G?

The serum targets Parvovirus B19 reactive IgG antibodies, making it suitable for detecting immune response to Parvovirus B19.

Is the Parvovirus B19 IgG Control Serum BC122G a ready-to-use product or does it require dilution?

The Parvovirus B19 IgG Control Serum BC122G is provided as a ready-to-use, pre-diluted serum optimized for use with SERION ELISA assays.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC122G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Parvovirus B19 IgG Control Serum BC122G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Cytomegalovirus IgG Control Serum BC109G

Brucella IgG Control Serum BC116G

Enterovirus IgG Control Serum BC133G

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgG Control Serum BC135G

Bordetella pertussis IgG Control Serum BC120G

Echinococcus IgG Control Serum BC107G

Aspergillus fumigatus IgG Control Serum BC132G

Diphtheria IgG Control Serum BC130G

Adenovirus IgG Control Serum BC128G

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G